New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6

Chest

Volumn 96, Issue 1, 1989, Pages 68-73

  Kohno, N ^a   Kyoizumi, S ^a   Awaya, Y ^a   Fukuhara, H ^a   Yamakido, M ^a   Akiyama, M ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CONTROLLED STUDY; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0024332651     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.96.1.68     Document Type: Article

References (16)

1. AA Liebow Definition and classification of interstitial pneumonias in human pathology. Prog Resp Res 8 1975 1 33
2. M Turner-Warwick B Burrows A Johnson Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 35 1980 171 180
3. M Yamaoka Y Fukuchi K Ishida K Yano H So M Harasawa Clinical status and prognosis of interstitial pulmonary diseases: investigation of 500 cases in Japan. 1984 Annual Report of the Research Group of Interstitial Pulmonary Diseases. 1985 Japanese Ministry of Health and Welfare Tokyo 5 14
4. M Turner-Warwick B Burrows A Johnson Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax 35 1980 593 599
5. BA Keogh J Bernardo GW Hunninghake BR Line DL Price RG Crystal Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. Am Rev Respir Dis 127 1983 18 22
6. N Kohno M Akiyama S Kyoizumi M Hakoda K Kobuke M Yamakido Monoclonal antibodies KL-3 and KL-6 against human pulmonary adenocarcinoma: I. characterization of the antibodies and their application in detection of tumor cells in pleural effusion. 1987 Radiation Effects Research Foundation Technical Report Hiroshima 2 87
7. N Kohno M Akiyama S Kyoizumi M Hakoda K Kobuke M Yamakido Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies KL-3 and KL-6 against lung adenocarcinoma. Japan J Clin Oncol 18 1988 203 216
8. RA DeRemee Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. JAMA 204 1968 1193 1195
9. RG Crystal PB Bitterman SI Rennard AJ Hance BA Keogh Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower repiratory tract. N Engl J Med 310 1984 154 166
10. RB Dreisin MI Schwarz AN Theofilopoulos RE Stanford Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med 298 1978 353 357
11. PL Haslam B Thompson I Mohammed PJ Townsend ME Hodson EJ Holborow Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol 37 1979 381 390
12. AF Gelb RB Dreisen JD Epstein JD Silverthorne Y Bickel M Fields Immune complexes, gallium lung scans, and bronchoalveolar lavage in idiopathic interstitial pneumonitis-fibrosis: a structure-function clinical study. Chest 84 1983 148 153
13. N Shigematsu S Hayashi K Yagawa K Ogata Comparison between assay systems of circulating immune complexes in interstitial pneumonias. 1985 Annual Report of the Research Group of Interstitial Pulmonary Diseases. 1986 Japanese Ministry of Health and Welfare Tokyo 117 120
14. RB Low KR Cutroneo GS Davis MS Giancola Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis. Lab Invest 48 1983 755 759
15. T Uehira A Shakado S Suetsugu H Umeda A Kurashima R Yoneda Measurement of type III procollagen N-terminal peptides in sera and bronchoalveolar lavage fluids of interstitial pulmonary diseases. 1984 Annual Report of the Research Group of Interstitial Pulmonary Diseases. 1985 Japanese Ministry of Health and Welfare Tokyo 55 60
16. SI Rennard RG Crystal Fibronectin in human bronchopulmonary lavage fluid: elevation in patients with interstitial lung disease. J Clin Invest 69 1982 113 122